Literature DB >> 19029477

Hypercoagulable states in cardiovascular disease.

Mark Y Chan1, Felicita Andreotti, Richard C Becker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19029477     DOI： 10.1161/CIRCULATIONAHA.108.778837

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  28 in total

Review 1.  Multivessel versus culprit-only revascularization: one time versus staged procedures for the ACS population.

Authors:  Pablo Codner; Ran Kornowski
Journal:  Curr Cardiol Rep       Date:  2012-08       Impact factor: 2.931

2.  Platelet factor 4 inhibits thrombomodulin-dependent activation of thrombin-activatable fibrinolysis inhibitor (TAFI) by thrombin.

Authors:  Laurent O Mosnier
Journal:  J Biol Chem       Date:  2010-11-01       Impact factor: 5.157

3.  Activation of NLRP3 inflammasome complex potentiates venous thrombosis in response to hypoxia.

Authors:  Neha Gupta; Anita Sahu; Amit Prabhakar; Tathagata Chatterjee; Tarun Tyagi; Babita Kumari; Nilofar Khan; Velu Nair; Nitin Bajaj; Manish Sharma; Mohammad Zahid Ashraf
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-18       Impact factor: 11.205

4.  The mystery of recurrent idiopathic cerebrovascular and coronary arterial thrombosis.

Authors:  Ali Raza Rajani; Wael Ezzat Mahmoud; Vagishwari Murugesan; Azan Salem BinBrek
Journal:  BMJ Case Rep       Date:  2014-11-24

5.  Fibrin, γ'-fibrinogen, and transclot pressure gradient control hemostatic clot growth during human blood flow over a collagen/tissue factor wound.

Authors:  Ryan W Muthard; John D Welsh; Lawrence F Brass; Scott L Diamond
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-01-22       Impact factor: 8.311

6.  Roles of Coagulation and fibrinolysis in angiotensin II-enhanced microvascular thrombosis.

Authors:  Elena Y Senchenkova; Janice Russell; Charles T Esmon; D Neil Granger
Journal:  Microcirculation       Date:  2014-07       Impact factor: 2.628

7.  Countervailing effects on atherogenesis and plaque stability: a paradoxical benefit of hypercoagulability?

Authors:  Jeff W Stevens; Steven R Lentz
Journal:  Circulation       Date:  2009-08-17       Impact factor: 29.690

Review 8.  Iron-induced fibrin in cardiovascular disease.

Authors:  Boguslaw Lipinski; Etheresia Pretorius
Journal:  Curr Neurovasc Res       Date:  2013-08       Impact factor: 1.990

9.  Association of optimism and pessimism with inflammation and hemostasis in the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Brita Roy; Ana V Diez-Roux; Teresa Seeman; Nalini Ranjit; Steven Shea; Mary Cushman
Journal:  Psychosom Med       Date:  2010-01-25       Impact factor: 4.312

10.  Circulating Thrombotic Risk Factors in Young Patients with Coronary Artery Disease Who Are on Statins and Anti-platelet Drugs.

Authors:  Reema George; Harikrishnan Sivadasanpillai; Narayani Jayakumari; Anugya Bhatt; Jissa V Thulaseedharan; Jaganmohan A Tharakan
Journal:  Indian J Clin Biochem       Date:  2015-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.